New Appointments

New Appointments

November 02, 2015

Trajan Scientific and Medical has significantly bolstered its global team, announcing four new appointments that add enviable skills and extensive experience to the organization as it continues to grow and expand around the world.

The appointments point to a strategic migration of the global footprint for Trajan, expanding in key markets such as Asia with the appointment of Takeyoshi Ide as Sales Manager Japan. Mr Ide brings significant expertise not only in chromatography, but also the life science market.

Bridging the gap between the academic world and real life is a major focus for Trajan, as demonstrated by the appointment of Dr Robert (Rob) Shellie as Chromatography Market Manager. Dr Shellie was Associate Professor of Chemistry at the University of Tasmania in Hobart, Australia prior to joining Trajan. With multiple achievements of international recognition Dr Shellie is well experienced at translating chromatography technologies into meaningful applications.

Trajan’s focus is on developing and commercialising technologies that enable analytical systems to be more selective, sensitive and specific for biological, environmental or food related measurements - especially those that can lead to portability, miniaturization and affordability.

The appointment of Dr Pawanbir Singh as Pathology Market Manager from medical device and life science organizations including Leica Biosystems and STEMCELL Technologies, is a tangible demonstration of the strategic importance placed on this focus. Dr Singh pursued a PhD at the Centre for Biological Engineering at Loughborough University where he worked on scale-up and process optimization of regenerative medicine based products, developing an industry investment readiness reference model for these products as part of his doctoral studies.

In other new appointment news, Dr Michelle Carr joins as Commercialization Manager based in Melbourne, Australia. Dr Carr was CEO of Telezon Limited, a technology company focussed on unique processes for polymer injection systems.

Chief Executive Officer of Trajan, Stephen Tomisich comments: "Trajan is proud to be expanding its global team with people who bring complementary experience to the table. We are serious about continuing the growth of our team around the world, all united in fulfilling our passion to develop technologies that will impact human wellbeing."




Also in News

Trajan Scientific and Medical announces partnership with award-winning PR consultancy LBPR to impact human wellbeing globally
Trajan Scientific and Medical announces partnership with award-winning PR consultancy LBPR to impact human wellbeing globally

July 25, 2017

Trajan Scientific and Medical has announced its investment in award-winning PR consultancy LBPR, based on an alignment of company values and a shared vision to impact human wellbeing around the world.

Read More

Trajan invests in Health Delivered - promoting pathways to better nutrition
Trajan invests in Health Delivered - promoting pathways to better nutrition

July 06, 2017

Trajan Scientific and Medical has invested in Health Delivered, an experienced team in dietetics, consumer health and digital platforms.

July 28th is the Australian showcase launch of the Health Delivered platform, and registered dietitians across Australia are invited to sign up to use the platform which will be rolled out for beta testing over the first two weeks of August.

Read More

On the cutting edge of 3D printing for portable devices
On the cutting edge of 3D printing for portable devices

June 20, 2017

ARC Future Fellow and Chief Investigator at the ARC Training Centre for Portable Analytical Separation Technologies (ASTech), Professor Michael Breadmore, has spent his research career working to simplify and speed up the analysis of chemical and biological samples, with an increasing emphasis on miniaturization.

Read More